Unicycive Therapeutics, Inc. reports leadership or board changes

Unicycive Therapeutics, Inc. filed an 8-K covering director or executive-officer changes and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.